Noncontrast MRI out-of-pocket expenses vary quite a bit depending on geography and population.
Outpatient out-of-pocket costs for knee MRI vary considerably across the country, with lower prices in more populous areas, according to a study published in the Journal of the American College of Radiology.
Researchers from the Mayo Clinic in Rochester, MN, sought to determine the variability in pricing for noncontrast knee MRI, based on geographic location and population.
A total of 122 outpatient centers from 43 localities were included in the study. Nonhospital outpatient radiology centers were randomly chosen in each state’s highest-population locality, based on a list generated from the ACR MRI Accreditation Program database. The areas had to have at least two but no more than three centers for study inclusion. The data were further divided by population brackets: 50,000 to 500,000, 500,000 to 1 million, and more than 1 million.
The researchers, posing as a 21-year-old male college student who needed a noncontrast knee MRI to assess a knee injury sustained while playing football, contacted the centers by phone to determine the lowest, out-of-pocket, bundled cost (technical fee plus professional fee). The median (interquartile range) costs were calculated within each locality and region, including Midwest, Northeast, South, and West regions.
The results showed that costs for the examination ranged from $259 to $2,042 across all centers. For centers within a locality, the difference between the minimum and maximum costs ranged considerably among centers. For centers within a locality, the difference between the minimum and maximum costs among centers ranged from $1,592 to $0; median cost differences between localities ranged from $1,488 to $325.
Median cost geographically:
The researchers concluded that out-of-pocket expenses for outpatient knee MRIs varied considerably, both locally and nationally.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).